GeneSegues Therapeutics Awarded Contract For Development of Nanocapsule-based Vaccine for Biodefense Pathogen
Company Collaborating With U.S. Army Researchers on Topically Applied DNA Vaccine GeneSegues Therapeutics, a leader in the targeted delivery of RNAi and DNA therapeutics and vaccines in cancer and infectious disease, announced today it was awarded…